Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 23, 2024 11:30 ET | Source: InventHelp

InventHelp Inventor Develops Improved Coverall Garment (ACC-146)

PITTSBURGH, Jan. 23, 2024 (GLOBE NEWSWIRE) -- “I thought there should be a way to prevent the upper portion of a coverall garment from touching the floor when using the restroom,” said an inventor,...
January 23, 2024 11:00 ET | Source: InventHelp

InventHelp Inventor Develops Modified Cooler to Stabilize Drinks (ACC-134)

PITTSBURGH, Jan. 23, 2024 (GLOBE NEWSWIRE) -- “I transported a cooler full of drinks and food on an ATV and some of the beverages exploded. I thought there should be a better way,” said an inventor,...
January 23, 2024 08:30 ET | Source: Nexalin Technology, Inc.

Nexalin Technology Awarded Key Patent Related to its Non-Invasive, Frequency-Based Deep-Brain Stimulation Device – the Transcranial Alternating Current Dynamic Frequency Stimulation (TACS) System

HOUSTON, TX, Jan. 23, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) today announced that the United States Patent and Trademark Office (USPTO)...
January 22, 2024 11:00 ET | Source: VenHub, an Autonomous Solutions Company

Revolutionary VenHub Ecosystem Patent Filed by Industry Leader Autonomous Solutions, Inc.

PASADENA, Calif., Jan. 22, 2024 (GLOBE NEWSWIRE) -- via IBN -- In a significant stride toward transforming the retail landscape, Autonomous Solutions, Inc. has filed for a patent that marks a new...
January 18, 2024 16:30 ET | Source: GH Research PLC

GH Research Announces Grant of European Patent Covering all Mebufotenin (5-MeO-DMT) and Mebufotenin Salt Products For Use in the Treatment of Major Depressive Disorder and Treatment-Resistant Depression

DUBLIN, Ireland, Jan. 18, 2024 (GLOBE NEWSWIRE) -- GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological...
January 18, 2024 13:53 ET | Source: Ensurge Micropower Inc.

Ensurge Micropower reçoit un avis d’acceptation de deux brevets américains supplémentaires pour sa technologie de microbatterie au lithium à semi-conducteurs

SAN JOSÉ, État de Californie, 18 janv. 2024 (GLOBE NEWSWIRE) -- Ensurge Micropower (OSE : ENSU, et OTCQB : ENMPY), ci-après « Ensurge » ou la « Société », un fournisseur de premier plan de...
January 18, 2024 13:53 ET | Source: Ensurge Micropower Inc.

Ensurge Micropower hat die Genehmigung für zwei weitere US-Patente für seine Festkörper-Lithium-Mikrobatterie-Technologie erhalten

SAN JOSE, Kalifornien, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Ensurge Micropower (OSE: ENSU und OTCQB: ENMPY) („Ensurge” oder das „Unternehmen“), ein führender Anbieter von...
January 18, 2024 06:50 ET | Source: Eagle Pharmaceuticals, Inc.

Eagle Pharmaceuticals Provides Update on Bendamustine Intellectual Property Portfolio

WOODCLIFF LAKE, N.J., Jan. 18, 2024 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today provided an update on its bendamustine intellectual property...
January 18, 2024 00:59 ET | Source: LLeida.net

Lleida.net obtains three new patents in South America, reinforcing its innovative edge in electronic communications

Madrid, 18th January.- Lleida.net, a publicly traded Spanish company (OTCQX: OTC.US, Euronext Growth: ALLLN.PA, BME Growth: LLN.MA), has strengthened its leadership in electronic communications with...
January 17, 2024 17:25 ET | Source: Ensurge Micropower Inc.

Ensurge Micropower Received Notice of Allowance for Two Additional U.S. Patents for its Solid-State Lithium Microbattery Technology

SAN JOSE, Calif., Jan. 17, 2024 (GLOBE NEWSWIRE) -- Ensurge Micropower (OSE: ENSU, and OTCQB: ENMPY) (“Ensurge” or the “Company”), a leading provider of solid-state lithium microbatteries for a new...